18 May 2021
BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes
Sponsored by Biotronik
Speaker:
J.F. Iglesias
Summary
Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.
Learning Objectives
- To review the role of ultrathin DES in optimising clinical outcomes in STEMI patients
- To learn about the BIOSTEMI trial and its new two-year outcomes
- To assess the impact of the BIOSTEMI trial on your daily practice
